101 related articles for article (PubMed ID: 27004938)
1. Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis Patients.
Fekih-Mrissa N; Sayeh A; Baffoun A; Beji M; Mrad M; Hmida J; Nsiri B
Ther Apher Dial; 2016 Apr; 20(2):107-11. PubMed ID: 27004938
[TBL] [Abstract][Full Text] [Related]
2. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia.
Fekih-Mrissa N; Klai S; Bafoun A; Nciri B; Hmida J; Gritli N
Ther Apher Dial; 2011 Feb; 15(1):40-3. PubMed ID: 21272251
[TBL] [Abstract][Full Text] [Related]
3. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.
Rios DR; Fernandes AP; Carvalho MG; Figueiredo RC; Guimarães DA; Reis DR; Simões e Silva AC; Gomes KB; Dusse LM
Clin Chim Acta; 2011 Feb; 412(5-6):425-9. PubMed ID: 21070754
[TBL] [Abstract][Full Text] [Related]
4. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
[TBL] [Abstract][Full Text] [Related]
5. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.
Brophy DF; Bukaveckas BL; Ferreira-Gonzalez A; Archer KJ; Martin EJ; Gehr TW
Hemodial Int; 2009 Jan; 13(1):19-26. PubMed ID: 19210273
[TBL] [Abstract][Full Text] [Related]
8. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
11. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
13. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
14. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
16. No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
Yanqing H; Fangping C; Qinzhi X; Zaifu J; Guangping W; Xiaoxia Z; Xiaoqun P; Xiaobo
Thromb Haemost; 2003 Mar; 89(3):446-51. PubMed ID: 12624626
[TBL] [Abstract][Full Text] [Related]
17. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
[TBL] [Abstract][Full Text] [Related]
18. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
19. Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden.
Androulakis NE; Tzenakis N; Nioti E; Spatharaki P; Vyzoukaki R; Papadopoulou A; Kokonozaki M; Alexandrakis MG
Nephron; 2015; 131(1):5-10. PubMed ID: 26418867
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]